Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
					Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





Chlorodiphenyl																				Related Pages
										May 1994
Immediately Dangerous to Life or Health Concentrations (IDLH)
**CAS numbers:** 53469-21-9 (42% Cl); 11097-69-1 (54% Cl)
**NIOSH REL:** 0.001 mg/m3 TWA; NIOSH considers chlorodiphenyl to be a potential occupational carcinogen as defined by the OSHA carcinogen policy [29 CFR 1990].
**Current OSHA PEL:** 42% Cl: 1 mg/m3 TWA [skin];
54% Cl: 0.5 mg/m3 TWA [skin]
**1989 OSHA PEL:** Same as current PEL
**1993-1994 ACGIH TLV:** 1 mg/m3 TWA [skin]; 0.5 mg/m3 TWA [skin] (54% Cl)
**Description of Substance:** Colorless to light-colored, viscous liquid with a mild, hydrocarbon odor.
**LEL:** . . Noncombustible Liquid
**Original (SCP) IDLH for chlorodiphenyl (42% Cl):** 10 mg/m3
**Basis for original (SCP) IDLH:** In the absence of any other toxicological data, the chosen IDLH is based on the human TCLO (resulting in an irritant effect) of 10 mg/m3 [Elkins 1959 cited by NIOSH 1976].
**Original (SCP) IDLH for chlorodiphenyl (54% Cl):** 5 mg/m3
**Basis for original (SCP) IDLH:** In the absence of human exposure data or data on acute animal exposure, data on chronic animal exposures were used to determine the IDLH. The chosen IDLH is based on inhalation exposure data reported by AIHA [1965] that indicated liver damage occurs in rats chronically exposed (7 hours/day for 83 exposures during 121 days) to 5.4 mg/m3 chlorodiphenyl (54% chlorine) [Treon et al. 1956].
**Short-term exposure guidelines:** None developed
**ACUTE TOXICITY DATA**
**Lethal dose data:**

**Species**
    **Reference**
    **Route**
    **LD50** **(mg/kg)**
    **LDLo** **(mg/kg)**
    **Adjusted LD**
    **Derived** **value**ChlorodiphenylMouse
    Tanaka et al. 1969
    oral
    1,900
    -----
    13,300 mg/m3
    1,330 mg/m3Chlorodiphenyl (42% C) Rat
    Bruckner et al. 1973
    oral
    4,250
    -----
    29,750 mg/m3
    2,975 mg/m3Chlorodiphenyl (54% Cl)Rat
    Garihoff et al. 1981
    oral
    1,010
    -----
    7,070 mg/m3
    707 mg/m3
 **Other animal data:** Chlorodiphenyl (42% Cl) had no discernable effects in cats, rabbits, guinea pigs, rats, and mice after 150 seven-hour exposures to 1.9 mg/m3 over 7 months [Treon et al. 1956]; 17 seven-hour exposures over 24 days at 8.6 mg/m3 also appeared to be noninjurious [Treon et al. 1956]. Slight, reversible, nonspecific liver injury was noted in cats, rabbits, guinea pigs, rats, and mice exposed to 1.5 mg/m3 of chlorodiphenyl (54% Cl) for 7 hours/day for 150 days; 5.4 mg/m3 resulted in more extensive but reversible liver damage [Treon et al. 1956].
 **Human data:** It has been reported that concentrations above 10 mg/m3 were unbearably irritating [Elkins 1959]. Several deaths due to atrophy of the liver have occurred among workers chronically exposed to the fumes of chlorodiphenyls and chloronaphthalenes [von Wedel et al. 1943].
 
 **Revised IDLH:** 5 mg/m3**Basis for revised IDLH:** The revised IDLH for chlorodiphenyl is 5 mg/m3 based on acute inhalation toxicity data in humans [Elkins 1959] and animals [Treon et al. 1956]. [Note: NIOSH recommends as part of its carcinogen policy that the "most protective" respirators be worn for chlorodiphenyl at concentrations above 0.001 mg/m3.]
**REFERENCES:**
1. AIHA [1965]. Chlorodiphenyls (containing 42% and 54% chlorine). In: Hygienic guide series. Am Ind Hyg Assoc J *26*:92-94.
2. Bruckner JV, Khanna KL, Cornish HH [1973]. Biological responses of the rat to polychlorinated biphenyls. Toxicol Appl Pharmacol *24*:434-448.
3. Elkins HB [1959]. Chemistry of industrial toxicology. 2nd ed. New York, NY: John Wiley & Sons, Inc., p. 153.
4. Garihoff LH, Cerra FE, Marks EM [1981]. Blood chemistry alterations in rats after single and multiple gavage administration of polychlorinated biphenyl. Toxicol Appl Pharmacol *60*:33-44.
5. NIOSH [1976]. TQ13560. Polychlorinated biphenyl (Aroclor 1242). In: Registry of toxic effects of chemical substances, 1976 ed. Cincinnati, OH: U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 76-191, p. 944.
6. Tanaka K, Fujita S, Komatsu F, Tamura N [1969]. Experimental subacute poisoning of chlorobiphenyls, particularly the influence on the serum lipids in rats. Fukuoka Igaku Zasshi *60*(6):544-547 (in Japanese).
7. Treon JF, Cleveland FP, Cappel J, Atchley RW [1956]. The toxicity of the vapors of Aroclor 1242® and Aroclor 1254®. Am Ind Hyg Assoc Q *17*:204-213.
8. von Wedel, Holla WA, Denton J [1943]. Observations on the toxic effects resulting from exposure to chlorinated naphthalene and chlorinated phenyls with suggestions for prevention. Rubber Age *53*:419-426.

			
							
								Page last reviewed:  December 4, 2014						Content
							source: 	National Institute for Occupational Safety and Health NIOSH Publications & Products
Immediately Dangerous To Life or Health (IDLH) Values
Table of IDLH Values
Criteria for Determining IDLH Values
Historical Documentation
Original (SCP) Values
Abbreviations for IDLH Documentation
Abbreviations for Journal Titles Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification/Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
					Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
					You will be subject to the destination website's privacy policy when you follow the link.
					CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue